BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 32042746)

  • 1. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
    Zhang B; Wang Q; Fu C; Jiang C; Ma S
    Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma.
    Li AL; Zhu YM; Gao LQ; Wei SY; Wang MT; Ma Q; Zheng YY; Li JH; Wang QF
    Anal Cell Pathol (Amst); 2021; 2021():4743971. PubMed ID: 33511023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hazard immune-related genes and tumor immune infiltrations in renal cell carcinoma.
    Chen H; Xie J; Jin P
    Am J Transl Res; 2020; 12(11):7096-7113. PubMed ID: 33312353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
    Zhang C; Li Z; Qi F; Hu X; Luo J
    Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer.
    Ye T; Feng J; Cui M; Yang J; Wan X; Xie D; Liu J
    Int J Womens Health; 2021; 13():991-1004. PubMed ID: 34712062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma.
    Lv Y; Jin P; Chen Z; Zhang P
    Am J Transl Res; 2020; 12(11):7510-7527. PubMed ID: 33312386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Autophagy in Tumor Immune Infiltration in Colorectal Cancer.
    Bian-Fang Y; Dong-Ning W; Dan T; Jian-Yu S; Shi-Yi W; Ben-Jun W; Xin D; Wen-Wen Z; Qing-Feng W; Yan Z
    Anal Cell Pathol (Amst); 2022; 2022():2055676. PubMed ID: 35321516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer.
    Lu X; Yuan Q; Zhang C; Wang S; Wei W
    Front Oncol; 2023; 13():1149193. PubMed ID: 37469408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 14. Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.
    Zhang C; Zheng Y; Li X; Hu X; Qi F; Luo J
    Ann Transl Med; 2019 Sep; 7(18):427. PubMed ID: 31700863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
    Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
    Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer.
    Du F; Zheng F; Han Y; Zhao J; Yuan P
    Front Pharmacol; 2022; 13():820437. PubMed ID: 35721151
    [No Abstract]   [Full Text] [Related]  

  • 17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
    Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
    Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying
    Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
    PeerJ; 2023; 11():e16618. PubMed ID: 38099311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes.
    Peng Z; Liu XY; Cheng Z; Kai W; Song Z
    Ann Transl Med; 2021 Oct; 9(20):1576. PubMed ID: 34790782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.